In ovarian cancer cells, estrogen has also been demonstrated to promote the expression of angiogenic factors such as nerve growth factor (NGF) and vascular endothelial growth factor (VEGF) through the action of ERα [237]. This evidence concerns the gene ESR1 and ovarian carcinoma.